DAX25.384 +0,5%Est506.008 +0,2%MSCI World4.343 -0,1%Top 10 Crypto12,28 +1,9%Nas23.661 ±-0,0%Bitcoin78.042 -0,1%Euro1,1686 +0,4%Öl63,31 +0,5%Gold4.625 +2,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Novo Nordisk A3EU6F Deutsche Telekom 555750 Bayer BAY001 TKMS thyssenkrupp Marine Systems TKMS00 DroneShield A2DMAA Allianz 840400 RENK RENK73 Amazon 906866 BASF BASF11 Siemens Energy ENER6Y Lufthansa 823212 Infineon 623100 Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX etwas höher -- Wall Street uneins -- Eli Lilly plant wohl Abivax-Übernahme -- NVIDIA, VW, Mercedes, Novo Nordisk, Rüstungsaktien, Amazon, DroneShield, Airbus, BYD im Fokus
Top News
Hot Stocks heute: Trade der Woche: Bereich um 25.500 Punkte - Discount Short (PK2NVK) Hot Stocks heute: Trade der Woche: Bereich um 25.500 Punkte - Discount Short (PK2NVK)
TKMS: Strategischer Durchbruch in Indien - ein 8 Mrd. Euro-Auftrag bahnt sich an! TKMS: Strategischer Durchbruch in Indien - ein 8 Mrd. Euro-Auftrag bahnt sich an!
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Regeneron Pharmaceuticals Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
673,80 EUR -10,80 EUR -1,58 %
STU
787,99 USD -8,25 USD -1,04 %
BTT
Regeneron Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.71,63 Mrd. EUR

KGV18,58Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN881535

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS75886F1075

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolREGN

Regeneron Pharmaceuticals Aktien News

DatumMeistgelesen
BenzingaHere's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Benzinga21 Analysts Assess Regeneron Pharmaceuticals: What You Need To Know
BenzingaPeering Into Regeneron Pharmaceuticals Inc's Recent Short Interest
Wer­bungRegeneron Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
ZacksThe Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
BenzingaHow Is The Market Feeling About Regeneron Pharmaceuticals Inc?
BenzingaHere's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
BenzingaHere's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
MotleyFool1 Reason Why Shares of Regeneron Pharmaceuticals Are Surging This Month
BenzingaHere's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
BenzingaLooking Into Regeneron Pharmaceuticals Inc's Recent Short Interest
BenzingaWayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
BenzingaHere's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
BenzingaForecasting The Future: 9 Analyst Projections For Regeneron Pharmaceuticals
BenzingaA Look Into Regeneron Pharmaceuticals Inc's Price Over Earnings
BenzingaWhat's Happening With Regeneron Pharmaceuticals Stock On Monday?
BenzingaWhere Regeneron Pharmaceuticals Stands With Analysts
BenzingaA Look Into Regeneron Pharmaceuticals Inc's Price Over Earnings
BenzingaThese Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings
BenzingaBeyond The Numbers: 15 Analysts Discuss Regeneron Pharmaceuticals Stock
BenzingaIs Regeneron Pharmaceuticals Gaining or Losing Market Support?
BenzingaRegeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga$1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
BenzingaAssessing Regeneron Pharmaceuticals: Insights From 26 Financial Analysts
BenzingaHere's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
BenzingaRegeneron Pharmaceuticals Unusual Options Activity For July 01
Benzinga$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
BenzingaHere's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
BenzingaForecasting The Future: 21 Analyst Projections For Regeneron Pharmaceuticals
BenzingaRegeneron Pharmaceuticals Unusual Options Activity For May 30
BenzingaElastic, Gap, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session
BenzingaHere's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
New York Times23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
FOX BusinessRegeneron Pharmaceuticals to buy bankrupt 23andMe in $256M deal
BenzingaBeyond The Numbers: 16 Analysts Discuss Regeneron Pharmaceuticals Stock
BenzingaPrice Over Earnings Overview: Regeneron Pharmaceuticals
BenzingaAssessing Regeneron Pharmaceuticals: Insights From 7 Financial Analysts
BenzingaIs Regeneron Pharmaceuticals Gaining or Losing Market Support?
ZacksThe Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals
BenzingaPrice Over Earnings Overview: Regeneron Pharmaceuticals
PR NewswireRegeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Lon...

Regeneron Pharmaceuticals News

Regeneron Pharmaceuticals News: auf dieser Seite finden Sie alle Regeneron Pharmaceuticals News und Nachrichten zur Regeneron Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Regeneron Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Regeneron Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.